Key trends include increased demand for pharmacological weight management, heightened adoption of GLP-1 therapies beyond diabetes, and improved patient adherence to long-term treatments
Pfizer Pill Obesity Treatment: Danuglipron Development Status UK Pfizer's danuglipron, an oral GLP-1 receptor agonist developed as a tablet for obesity treatment, has not progressed to Phase 3 trials and is not approved in the UK
Though individual needs vary, try to get 79 hours of sleep per night
Who it helps : Women with PCOS or insulin resistance may see benefits like better blood sugar levels, weight management, and reduced PCOS symptoms
The Therapeutic Potential of Apigenin
In the original study, FOXO4-DRI showed 11.73-fold selectivity for senescent versus non-senescent human fibroblasts